COVID Vaccine Maker, Cancer Biotech IPOs Total $231M
Vaccitech, co-inventor of a COVID-19 vaccine, and Werewolf Therapeutics, a cancer-focused biotechnology firm, went public Friday after raising $231 million combined in a pair of initial public offerings steered by four law...To view the full article, register now.
Already a subscriber? Click here to view full article